nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.117	0.285	CbGbCtD
Raloxifene—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0823	0.201	CbGbCtD
Raloxifene—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0556	0.136	CbGbCtD
Raloxifene—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.053	0.13	CbGbCtD
Raloxifene—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0473	0.116	CbGbCtD
Raloxifene—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0277	0.0679	CbGbCtD
Raloxifene—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0262	0.0641	CbGbCtD
Raloxifene—Flavoxate—PDE4A—chronic obstructive pulmonary disease	0.00943	1	CrCbGaD
Raloxifene—ESR2—respiratory system—chronic obstructive pulmonary disease	0.00177	0.0794	CbGeAlD
Raloxifene—Influenza—Montelukast—chronic obstructive pulmonary disease	0.00176	0.00447	CcSEcCtD
Raloxifene—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.00176	0.00447	CcSEcCtD
Raloxifene—Embolism—Prednisone—chronic obstructive pulmonary disease	0.00175	0.00446	CcSEcCtD
Raloxifene—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00175	0.00445	CcSEcCtD
Raloxifene—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00175	0.00445	CcSEcCtD
Raloxifene—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00175	0.00444	CcSEcCtD
Raloxifene—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00175	0.00443	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00174	0.00441	CcSEcCtD
Raloxifene—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00438	CcSEcCtD
Raloxifene—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00438	CcSEcCtD
Raloxifene—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.0017	0.00431	CcSEcCtD
Raloxifene—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.00169	0.00429	CcSEcCtD
Raloxifene—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00165	0.00418	CcSEcCtD
Raloxifene—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00414	CcSEcCtD
Raloxifene—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.0041	CcSEcCtD
Raloxifene—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00159	0.00404	CcSEcCtD
Raloxifene—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.00158	0.00401	CcSEcCtD
Raloxifene—ESR2—connective tissue—chronic obstructive pulmonary disease	0.00156	0.0699	CbGeAlD
Raloxifene—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.00156	0.00395	CcSEcCtD
Raloxifene—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.00395	CcSEcCtD
Raloxifene—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.00156	0.00395	CcSEcCtD
Raloxifene—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.00395	CcSEcCtD
Raloxifene—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00387	CcSEcCtD
Raloxifene—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00381	CcSEcCtD
Raloxifene—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00381	CcSEcCtD
Raloxifene—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00374	CcSEcCtD
Raloxifene—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00373	CcSEcCtD
Raloxifene—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00373	CcSEcCtD
Raloxifene—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00368	CcSEcCtD
Raloxifene—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.00366	CcSEcCtD
Raloxifene—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00144	0.00366	CcSEcCtD
Raloxifene—ESR2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00143	0.0639	CbGeAlD
Raloxifene—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00362	CcSEcCtD
Raloxifene—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00362	CcSEcCtD
Raloxifene—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.0036	CcSEcCtD
Raloxifene—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00142	0.0036	CcSEcCtD
Raloxifene—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.0036	CcSEcCtD
Raloxifene—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00142	0.0036	CcSEcCtD
Raloxifene—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.0036	CcSEcCtD
Raloxifene—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00359	CcSEcCtD
Raloxifene—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00359	CcSEcCtD
Raloxifene—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00141	0.00358	CcSEcCtD
Raloxifene—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00358	CcSEcCtD
Raloxifene—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00358	CcSEcCtD
Raloxifene—AOX1—bronchus—chronic obstructive pulmonary disease	0.0014	0.0629	CbGeAlD
Raloxifene—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.0014	0.00356	CcSEcCtD
Raloxifene—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.0014	0.00355	CcSEcCtD
Raloxifene—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00139	0.00353	CcSEcCtD
Raloxifene—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00139	0.00353	CcSEcCtD
Raloxifene—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00351	CcSEcCtD
Raloxifene—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00138	0.0035	CcSEcCtD
Raloxifene—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.0035	CcSEcCtD
Raloxifene—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00346	CcSEcCtD
Raloxifene—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00345	CcSEcCtD
Raloxifene—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00344	CcSEcCtD
Raloxifene—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00343	CcSEcCtD
Raloxifene—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00342	CcSEcCtD
Raloxifene—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.0034	CcSEcCtD
Raloxifene—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00339	CcSEcCtD
Raloxifene—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00339	CcSEcCtD
Raloxifene—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00339	CcSEcCtD
Raloxifene—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00133	0.00338	CcSEcCtD
Raloxifene—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.00338	CcSEcCtD
Raloxifene—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00338	CcSEcCtD
Raloxifene—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00132	0.00335	CcSEcCtD
Raloxifene—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00335	CcSEcCtD
Raloxifene—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00335	CcSEcCtD
Raloxifene—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00335	CcSEcCtD
Raloxifene—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00132	0.00334	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00333	CcSEcCtD
Raloxifene—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00332	CcSEcCtD
Raloxifene—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.00328	CcSEcCtD
Raloxifene—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.00325	CcSEcCtD
Raloxifene—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.00322	CcSEcCtD
Raloxifene—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.00322	CcSEcCtD
Raloxifene—AOX1—trachea—chronic obstructive pulmonary disease	0.00126	0.0565	CbGeAlD
Raloxifene—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.0032	CcSEcCtD
Raloxifene—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.0032	CcSEcCtD
Raloxifene—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.0032	CcSEcCtD
Raloxifene—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00126	0.00319	CcSEcCtD
Raloxifene—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00124	0.00316	CcSEcCtD
Raloxifene—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00124	0.00315	CcSEcCtD
Raloxifene—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00313	CcSEcCtD
Raloxifene—CYP19A1—connective tissue—chronic obstructive pulmonary disease	0.00123	0.0551	CbGeAlD
Raloxifene—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00312	CcSEcCtD
Raloxifene—ESR1—respiratory system—chronic obstructive pulmonary disease	0.00121	0.0544	CbGeAlD
Raloxifene—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00308	CcSEcCtD
Raloxifene—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00305	CcSEcCtD
Raloxifene—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00305	CcSEcCtD
Raloxifene—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.00303	CcSEcCtD
Raloxifene—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00118	0.003	CcSEcCtD
Raloxifene—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00299	CcSEcCtD
Raloxifene—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00296	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00293	CcSEcCtD
Raloxifene—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00291	CcSEcCtD
Raloxifene—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00288	CcSEcCtD
Raloxifene—SIGMAR1—bronchus—chronic obstructive pulmonary disease	0.00113	0.0506	CbGeAlD
Raloxifene—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00111	0.00283	CcSEcCtD
Raloxifene—SIGMAR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00111	0.0495	CbGeAlD
Raloxifene—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.0011	0.0494	CbGeAlD
Raloxifene—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.00279	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00277	CcSEcCtD
Raloxifene—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00277	CcSEcCtD
Raloxifene—Cough—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00277	CcSEcCtD
Raloxifene—Cough—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00272	CcSEcCtD
Raloxifene—ESR1—connective tissue—chronic obstructive pulmonary disease	0.00107	0.0478	CbGeAlD
Raloxifene—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.0027	CcSEcCtD
Raloxifene—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.0027	CcSEcCtD
Raloxifene—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00107	0.0027	CcSEcCtD
Raloxifene—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00107	0.0027	CcSEcCtD
Raloxifene—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.0027	CcSEcCtD
Raloxifene—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00107	0.0027	CcSEcCtD
Raloxifene—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.0027	CcSEcCtD
Raloxifene—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.00269	CcSEcCtD
Raloxifene—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.00269	CcSEcCtD
Raloxifene—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00269	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00269	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00269	CcSEcCtD
Raloxifene—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00265	CcSEcCtD
Raloxifene—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00265	CcSEcCtD
Raloxifene—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00264	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00263	CcSEcCtD
Raloxifene—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00263	CcSEcCtD
Raloxifene—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00262	CcSEcCtD
Raloxifene—SIGMAR1—trachea—chronic obstructive pulmonary disease	0.00102	0.0454	CbGeAlD
Raloxifene—Infection—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00258	CcSEcCtD
Raloxifene—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00258	CcSEcCtD
Raloxifene—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00255	CcSEcCtD
Raloxifene—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00255	CcSEcCtD
Raloxifene—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00255	CcSEcCtD
Raloxifene—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.001	0.00254	CcSEcCtD
Raloxifene—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00254	CcSEcCtD
Raloxifene—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.001	0.00254	CcSEcCtD
Raloxifene—Infection—Montelukast—chronic obstructive pulmonary disease	0.000994	0.00252	CcSEcCtD
Raloxifene—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000992	0.00252	CcSEcCtD
Raloxifene—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000992	0.00252	CcSEcCtD
Raloxifene—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000981	0.00249	CcSEcCtD
Raloxifene—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000979	0.00249	CcSEcCtD
Raloxifene—ESR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000978	0.0438	CbGeAlD
Raloxifene—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000972	0.00247	CcSEcCtD
Raloxifene—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000958	0.00243	CcSEcCtD
Raloxifene—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000949	0.00241	CcSEcCtD
Raloxifene—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000946	0.0024	CcSEcCtD
Raloxifene—ESR2—lung—chronic obstructive pulmonary disease	0.000941	0.0421	CbGeAlD
Raloxifene—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00094	0.00239	CcSEcCtD
Raloxifene—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000937	0.00238	CcSEcCtD
Raloxifene—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000932	0.00237	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00093	0.00236	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00093	0.00236	CcSEcCtD
Raloxifene—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000924	0.00235	CcSEcCtD
Raloxifene—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000924	0.00235	CcSEcCtD
Raloxifene—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000918	0.00233	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000911	0.00231	CcSEcCtD
Raloxifene—AOX1—lung—chronic obstructive pulmonary disease	0.000906	0.0406	CbGeAlD
Raloxifene—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000905	0.0023	CcSEcCtD
Raloxifene—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000899	0.00228	CcSEcCtD
Raloxifene—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000899	0.00228	CcSEcCtD
Raloxifene—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000897	0.0402	CbGeAlD
Raloxifene—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000887	0.00225	CcSEcCtD
Raloxifene—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000885	0.00225	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000882	0.00224	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000882	0.00224	CcSEcCtD
Raloxifene—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00088	0.00224	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000879	0.00223	CcSEcCtD
Raloxifene—Pain—Formoterol—chronic obstructive pulmonary disease	0.000873	0.00222	CcSEcCtD
Raloxifene—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000873	0.00222	CcSEcCtD
Raloxifene—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000872	0.00221	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000864	0.00219	CcSEcCtD
Raloxifene—Pain—Montelukast—chronic obstructive pulmonary disease	0.000855	0.00217	CcSEcCtD
Raloxifene—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000853	0.00217	CcSEcCtD
Raloxifene—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000849	0.00216	CcSEcCtD
Raloxifene—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000846	0.00215	CcSEcCtD
Raloxifene—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000845	0.00215	CcSEcCtD
Raloxifene—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000843	0.00214	CcSEcCtD
Raloxifene—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000841	0.00213	CcSEcCtD
Raloxifene—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000837	0.00212	CcSEcCtD
Raloxifene—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000835	0.00212	CcSEcCtD
Raloxifene—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000835	0.00212	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000832	0.00211	CcSEcCtD
Raloxifene—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000825	0.00209	CcSEcCtD
Raloxifene—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000818	0.00208	CcSEcCtD
Raloxifene—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000807	0.00205	CcSEcCtD
Raloxifene—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000807	0.00205	CcSEcCtD
Raloxifene—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000807	0.00205	CcSEcCtD
Raloxifene—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000807	0.00205	CcSEcCtD
Raloxifene—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000805	0.00204	CcSEcCtD
Raloxifene—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000798	0.00203	CcSEcCtD
Raloxifene—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000797	0.00202	CcSEcCtD
Raloxifene—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000797	0.00202	CcSEcCtD
Raloxifene—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000793	0.00201	CcSEcCtD
Raloxifene—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000791	0.00201	CcSEcCtD
Raloxifene—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000791	0.00201	CcSEcCtD
Raloxifene—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000788	0.002	CcSEcCtD
Raloxifene—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000762	0.00194	CcSEcCtD
Raloxifene—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000762	0.00194	CcSEcCtD
Raloxifene—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000752	0.00191	CcSEcCtD
Raloxifene—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000738	0.0331	CbGeAlD
Raloxifene—SIGMAR1—lung—chronic obstructive pulmonary disease	0.000729	0.0326	CbGeAlD
Raloxifene—HTR2B—lung—chronic obstructive pulmonary disease	0.000728	0.0326	CbGeAlD
Raloxifene—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000699	0.00177	CcSEcCtD
Raloxifene—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000699	0.00177	CcSEcCtD
Raloxifene—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000684	0.00174	CcSEcCtD
Raloxifene—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000675	0.00171	CcSEcCtD
Raloxifene—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000675	0.00171	CcSEcCtD
Raloxifene—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000661	0.00168	CcSEcCtD
Raloxifene—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00066	0.00168	CcSEcCtD
Raloxifene—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000649	0.00165	CcSEcCtD
Raloxifene—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000649	0.00165	CcSEcCtD
Raloxifene—ESR1—lung—chronic obstructive pulmonary disease	0.000645	0.0289	CbGeAlD
Raloxifene—Rash—Formoterol—chronic obstructive pulmonary disease	0.000644	0.00163	CcSEcCtD
Raloxifene—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000644	0.00163	CcSEcCtD
Raloxifene—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000643	0.00163	CcSEcCtD
Raloxifene—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000643	0.00163	CcSEcCtD
Raloxifene—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000643	0.00163	CcSEcCtD
Raloxifene—Headache—Formoterol—chronic obstructive pulmonary disease	0.00064	0.00162	CcSEcCtD
Raloxifene—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00064	0.00162	CcSEcCtD
Raloxifene—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000638	0.00162	CcSEcCtD
Raloxifene—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000636	0.00161	CcSEcCtD
Raloxifene—Rash—Montelukast—chronic obstructive pulmonary disease	0.000631	0.0016	CcSEcCtD
Raloxifene—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00063	0.0016	CcSEcCtD
Raloxifene—Depression—Prednisone—chronic obstructive pulmonary disease	0.000628	0.0016	CcSEcCtD
Raloxifene—Headache—Montelukast—chronic obstructive pulmonary disease	0.000627	0.00159	CcSEcCtD
Raloxifene—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000613	0.00156	CcSEcCtD
Raloxifene—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000609	0.00155	CcSEcCtD
Raloxifene—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000608	0.00154	CcSEcCtD
Raloxifene—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000608	0.00154	CcSEcCtD
Raloxifene—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000607	0.00154	CcSEcCtD
Raloxifene—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000607	0.00154	CcSEcCtD
Raloxifene—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000607	0.00154	CcSEcCtD
Raloxifene—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000604	0.00153	CcSEcCtD
Raloxifene—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000596	0.00151	CcSEcCtD
Raloxifene—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000594	0.00151	CcSEcCtD
Raloxifene—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000573	0.00145	CcSEcCtD
Raloxifene—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000556	0.00141	CcSEcCtD
Raloxifene—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000544	0.00138	CcSEcCtD
Raloxifene—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000535	0.00136	CcSEcCtD
Raloxifene—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000525	0.00133	CcSEcCtD
Raloxifene—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000513	0.0013	CcSEcCtD
Raloxifene—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.0005	0.00127	CcSEcCtD
Raloxifene—CYP2B6—lung—chronic obstructive pulmonary disease	0.000476	0.0213	CbGeAlD
Raloxifene—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000473	0.0012	CcSEcCtD
Raloxifene—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000442	0.00112	CcSEcCtD
Raloxifene—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000442	0.00112	CcSEcCtD
Raloxifene—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000433	0.0011	CcSEcCtD
Raloxifene—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000419	0.00106	CcSEcCtD
Raloxifene—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000419	0.00106	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000416	0.00106	CcSEcCtD
Raloxifene—Infection—Prednisone—chronic obstructive pulmonary disease	0.000399	0.00101	CcSEcCtD
Raloxifene—Shock—Prednisone—chronic obstructive pulmonary disease	0.000395	0.001	CcSEcCtD
Raloxifene—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000394	0.001	CcSEcCtD
Raloxifene—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00039	0.000991	CcSEcCtD
Raloxifene—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000389	0.000986	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000366	0.00093	CcSEcCtD
Raloxifene—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000366	0.000929	CcSEcCtD
Raloxifene—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000923	CcSEcCtD
Raloxifene—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000354	0.000898	CcSEcCtD
Raloxifene—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.000885	CcSEcCtD
Raloxifene—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000348	0.000885	CcSEcCtD
Raloxifene—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000346	0.00088	CcSEcCtD
Raloxifene—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000834	CcSEcCtD
Raloxifene—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000329	0.000834	CcSEcCtD
Raloxifene—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000318	0.000807	CcSEcCtD
Raloxifene—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000318	0.000807	CcSEcCtD
Raloxifene—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000698	CcSEcCtD
Raloxifene—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000675	CcSEcCtD
Raloxifene—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000649	CcSEcCtD
Raloxifene—Rash—Prednisone—chronic obstructive pulmonary disease	0.000253	0.000643	CcSEcCtD
Raloxifene—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000253	0.000643	CcSEcCtD
Raloxifene—Headache—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000639	CcSEcCtD
Raloxifene—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000606	CcSEcCtD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000218	0.00131	CbGpPWpGaD
Raloxifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000215	0.0013	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000213	0.00128	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000211	0.00127	CbGpPWpGaD
Raloxifene—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00021	0.00127	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00021	0.00127	CbGpPWpGaD
Raloxifene—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000207	0.00125	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000206	0.00124	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000202	0.00122	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.0002	0.0012	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000196	0.00118	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000195	0.00118	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000194	0.00117	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000194	0.00117	CbGpPWpGaD
Raloxifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000193	0.00116	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000193	0.00116	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000193	0.00116	CbGpPWpGaD
Raloxifene—EBP—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000192	0.00116	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000192	0.00116	CbGpPWpGaD
Raloxifene—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00019	0.00115	CbGpPWpGaD
Raloxifene—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00019	0.00115	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000189	0.00114	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000187	0.00113	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000187	0.00112	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	0.000185	0.00112	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000183	0.0011	CbGpPWpGaD
Raloxifene—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00018	0.00109	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00018	0.00109	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000179	0.00108	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000178	0.00107	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000177	0.00107	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000177	0.00107	CbGpPWpGaD
Raloxifene—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000175	0.00106	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000175	0.00105	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000174	0.00105	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000172	0.00104	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00017	0.00103	CbGpPWpGaD
Raloxifene—EBP—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.00102	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000169	0.00102	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000169	0.00102	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000166	0.001	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000164	0.000992	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000163	0.000984	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000163	0.000984	CbGpPWpGaD
Raloxifene—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000161	0.000971	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000157	0.000948	CbGpPWpGaD
Raloxifene—AOX1—Disease—HDAC2—chronic obstructive pulmonary disease	0.000156	0.000943	CbGpPWpGaD
Raloxifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.000943	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000156	0.00094	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000155	0.000936	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000155	0.000933	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000155	0.000933	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000154	0.000931	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000154	0.000929	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000154	0.000928	CbGpPWpGaD
Raloxifene—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.00092	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000152	0.000915	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00015	0.000907	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000149	0.0009	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000148	0.000892	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000148	0.00089	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000148	0.00089	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000147	0.000887	CbGpPWpGaD
Raloxifene—AOX1—Disease—KL—chronic obstructive pulmonary disease	0.000145	0.000877	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000141	0.00085	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000141	0.000848	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000138	0.000829	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000137	0.000827	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000136	0.000822	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000136	0.00082	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000135	0.000812	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000133	0.000803	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000132	0.000799	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00013	0.000781	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	0.000124	0.000751	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00012	0.000722	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000119	0.000719	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	0.000119	0.000715	CbGpPWpGaD
Raloxifene—EBP—Metabolism—ALB—chronic obstructive pulmonary disease	0.000115	0.000696	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.000689	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000114	0.000685	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000113	0.000682	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.00068	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000112	0.000674	CbGpPWpGaD
Raloxifene—EBP—Metabolism—NOS3—chronic obstructive pulmonary disease	0.00011	0.000666	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.00011	0.000662	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.000659	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000109	0.000659	CbGpPWpGaD
Raloxifene—AOX1—Disease—ERBB3—chronic obstructive pulmonary disease	0.000109	0.000657	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000108	0.000651	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000108	0.00065	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000107	0.000643	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000107	0.000642	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000103	0.000623	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000101	0.000607	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.0001	0.000604	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.93e-05	0.000599	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	9.88e-05	0.000596	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.74e-05	0.000587	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.74e-05	0.000587	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	9.69e-05	0.000584	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.53e-05	0.000575	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.53e-05	0.000575	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	9.47e-05	0.000571	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.41e-05	0.000568	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	9.41e-05	0.000567	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.4e-05	0.000567	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.12e-05	0.00055	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.11e-05	0.00055	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	9.11e-05	0.000549	CbGpPWpGaD
Raloxifene—AOX1—Disease—NOS2—chronic obstructive pulmonary disease	9.09e-05	0.000548	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.87e-05	0.000535	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.84e-05	0.000533	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.81e-05	0.000531	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.76e-05	0.000528	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.7e-05	0.000525	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.65e-05	0.000522	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.64e-05	0.000521	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.6e-05	0.000519	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—CTGF—chronic obstructive pulmonary disease	8.37e-05	0.000505	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.34e-05	0.000503	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.32e-05	0.000502	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.32e-05	0.000502	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.3e-05	0.000501	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.29e-05	0.0005	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	8.29e-05	0.0005	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.25e-05	0.000497	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.19e-05	0.000494	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.18e-05	0.000493	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.06e-05	0.000486	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	8.02e-05	0.000484	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.97e-05	0.00048	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	7.93e-05	0.000478	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.9e-05	0.000476	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	7.8e-05	0.00047	CbGpPWpGaD
Raloxifene—AOX1—Disease—SERPINE1—chronic obstructive pulmonary disease	7.65e-05	0.000462	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.61e-05	0.000459	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.57e-05	0.000457	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	7.57e-05	0.000456	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.46e-05	0.00045	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.43e-05	0.000448	CbGpPWpGaD
Raloxifene—AOX1—Disease—NOS3—chronic obstructive pulmonary disease	7.31e-05	0.000441	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.27e-05	0.000438	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.93e-05	0.000418	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.91e-05	0.000417	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.7e-05	0.000404	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	6.68e-05	0.000403	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.67e-05	0.000402	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ALB—chronic obstructive pulmonary disease	6.4e-05	0.000386	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.2e-05	0.000374	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.12e-05	0.000369	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.09e-05	0.000367	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.94e-05	0.000358	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.72e-05	0.000345	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.66e-05	0.000341	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.59e-05	0.000337	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.51e-05	0.000332	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.22e-05	0.000315	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.18e-05	0.000312	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.15e-05	0.000311	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.13e-05	0.00031	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.12e-05	0.000309	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.11e-05	0.000308	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.07e-05	0.000306	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.87e-05	0.000293	CbGpPWpGaD
Raloxifene—AOX1—Disease—TGFB1—chronic obstructive pulmonary disease	4.83e-05	0.000291	CbGpPWpGaD
Raloxifene—AOX1—Disease—EGFR—chronic obstructive pulmonary disease	4.74e-05	0.000286	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.71e-05	0.000284	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.7e-05	0.000284	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.68e-05	0.000282	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.67e-05	0.000282	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.67e-05	0.000281	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.65e-05	0.00028	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.47e-05	0.00027	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.43e-05	0.000267	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.38e-05	0.000264	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.35e-05	0.000262	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	4.33e-05	0.000261	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.31e-05	0.00026	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.3e-05	0.000259	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.27e-05	0.000257	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.24e-05	0.000256	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.16e-05	0.000251	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.08e-05	0.000246	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.04e-05	0.000244	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4e-05	0.000241	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	3.95e-05	0.000238	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.89e-05	0.000234	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	3.82e-05	0.00023	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.8e-05	0.000229	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.64e-05	0.00022	CbGpPWpGaD
Raloxifene—AOX1—Disease—IL6—chronic obstructive pulmonary disease	3.64e-05	0.00022	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.59e-05	0.000216	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.54e-05	0.000213	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.53e-05	0.000213	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.42e-05	0.000206	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.4e-05	0.000205	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.31e-05	0.000199	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.3e-05	0.000199	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.26e-05	0.000197	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.16e-05	0.000191	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.16e-05	0.000191	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.13e-05	0.000188	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.12e-05	0.000188	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.12e-05	0.000188	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.04e-05	0.000183	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	3e-05	0.000181	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.98e-05	0.00018	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.84e-05	0.000171	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.79e-05	0.000168	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.76e-05	0.000167	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.65e-05	0.00016	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.63e-05	0.000158	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.52e-05	0.000152	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.5e-05	0.000151	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.48e-05	0.00015	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.4e-05	0.000145	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.37e-05	0.000143	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.35e-05	0.000142	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.32e-05	0.00014	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.28e-05	0.000138	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.24e-05	0.000135	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	2.12e-05	0.000128	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.12e-05	0.000128	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.1e-05	0.000127	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.06e-05	0.000124	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.05e-05	0.000124	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.03e-05	0.000123	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.02e-05	0.000122	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.95e-05	0.000118	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.9e-05	0.000115	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.88e-05	0.000113	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.84e-05	0.000111	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.8e-05	0.000108	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.72e-05	0.000104	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.71e-05	0.000103	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.7e-05	0.000102	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.63e-05	9.83e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.61e-05	9.7e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.57e-05	9.45e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.55e-05	9.36e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.55e-05	9.33e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.54e-05	9.26e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.5e-05	9.03e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.42e-05	8.56e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.42e-05	8.54e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.29e-05	7.78e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.18e-05	7.12e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	9.65e-06	5.82e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	9.23e-06	5.57e-05	CbGpPWpGaD
